Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
Boston Scientific Deferred Tax Assets and Other Non-Current Assets increased by 10.1% to $2.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $1.83B to $2.05B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows relatively stable performance with a -0.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.44B | $1.41B | $1.38B | $1.57B | $1.60B | $1.50B | $1.48B | $1.60B | $1.61B | $1.53B | $1.60B | $1.55B | $1.64B | $1.75B | $1.83B | $1.86B | $1.83B | $1.87B | $2.05B |
| QoQ Change | — | -11.4% | -2.4% | -2.5% | +14.1% | +2.1% | -6.4% | -1.2% | +7.6% | +0.6% | -4.6% | +4.2% | -2.8% | +5.9% | +6.8% | +4.6% | +1.6% | -1.7% | +1.9% | +10.1% |
| YoY Change | — | — | — | — | -3.7% | +10.9% | +6.4% | +7.8% | +1.7% | +0.2% | +2.1% | +7.7% | -2.8% | +2.3% | +14.6% | +14.9% | +20.2% | +11.6% | +6.4% | +12.0% |
Range$1.38B – $2.05B
CAGR+5.0%
Avg YoY Growth+7.0%
Median YoY Growth+7.0%
Current Streak2 quarters growth
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's deferred tax assets and other non-current assets?
- Boston Scientific (BSX) reported deferred tax assets and other non-current assets of $2.05B in Q1 2026.
- How has Boston Scientific's deferred tax assets and other non-current assets changed year-over-year?
- Boston Scientific's deferred tax assets and other non-current assets increased by 12.0% year-over-year, from $1.83B to $2.05B.
- What is the long-term trend for Boston Scientific's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Boston Scientific's deferred tax assets and other non-current assets has grown at a -0.6% compound annual growth rate (CAGR), from $1.92B to $1.87B.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.